THE UNIVERSITY OF IOWA

IOWA CITY, Iowa

Total Received

$334.2M

Total Awards

112

State

Iowa

Last Updated

Mar 20, 2026

Yearly Funding Trend

$276.8M

$53.5M

$3.9M

Top 50 Awards to THE UNIVERSITY OF IOWA

Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.

Download CSV

Top 50 Awards to THE UNIVERSITY OF IOWA
Award	Awarding Agency	Program	Place	FY	Obligation
ASST_NON_U01HL089897_075 (1 OF 2) GENETIC EPIDEMIOLOGY OF COPD - PROJECT SUMMARY / ABSTRACT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), THE THIRD LEADING CAUSE OF DEATH IN THE UNITED STATES, IS A HETERO…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$53,344,199
ASST_NON_UM1AI151958_075 ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER - PROJECT SUMMARY/ABSTRACT ATOPIC DERMATITIS (AD) IS THE MOST COMMON CHRONIC INFLAMMATORY SKIN DISEASE IN THE GENERAL POPULATI…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$33,715,767
CONT_AWD_75N92024F00001_7529_75N92023D00011_7529 GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) 2024 - 2025 TASK ORDER FOR TASK AREA A: COLLECTION OF COPDGENE STUDY DATA AND BIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY.	Department of Health and Human Services National Institutes of Health	—	DENVER, CO-01	2024	$9,298,220
CONT_AWD_75N92025F00001_7529_75N92023D00011_7529 COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026	Department of Health and Human Services National Institutes of Health	—	DENVER, CO-01	2025	$9,292,344
ASST_NON_P01HL132821_075 DEFINING MOLECULAR PHENOTYPES OF EXACERBATION PRONE ASTHMATICS - VIRAL EXACERBATIONS OF ASTHMA ARE RESPONSIBLE FOR 1.8 MILLION EMERGENCY ROOM VISITS AND 0.4 MILLION HOSPITALIZATIO…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2025	$8,964,654
ASST_NON_U01HL138689_075 AN ASTHMA COLLABORATION TO REDUCE CHILDHOOD ASTHMA DISPARITIES ON THE NAVAJO NATION - PROJECT SUMMARY/ABSTRACT ASTHMA PREVALENCE AMONG CHILDREN ON THE NAVAJO NATION, THE LARGEST…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$8,234,395
CONT_AWD_75N92023F00001_7529_75N92023D00011_7529 COPD GENE - NCE MOD TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA AND BIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY	Department of Health and Human Services National Institutes of Health	—	DENVER, CO-01	2024	$8,193,539
ASST_NON_R01HL077328_075 CERAMIDE-INDUCED DESTRUCTION IN EMPHYSEMA - ABSTRACT A HALLMARK OF EMPHYSEMA IS THE NET LOSS OF CELLS THAT FORM ALVEOLAR UNITS REQUIRED FOR GAS EXCHANGE, DUE TO INCREASED INJURY A…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$7,437,239
ASST_NON_R01HL109557_075 MECHANISMS AND CONSEQUENCES OF GENE INDUCTION BY GLUCOCORTICOIDS IN AIRWAY SMOOTH MUSCLE - GLUCOCORTICOIDS (GCS, GENERICALLY KNOWN AS “STEROIDS”) ARE EXCEPTIONALLY EFFECTIVE DRUGS…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$7,231,146
ASST_NON_R35HL140039_075 LUNG MACROPHAGE PROGRAMMING IN ACUTE LUNG INJURY - PROJECT SUMMARY ACUTE INFLAMMATORY LUNG DISEASES AFFECT OVER 450 MILLION PEOPLE WORLDWIDE EACH YEAR. PATHOLOGIC HALLMARKS INCLUD…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$6,398,735
ASST_NON_H3700066_075 BLACK LUNG - APPLICANT ORGANIZATION NAME: NATIONAL JEWISH HEALTH ADDRESS: 1400 JACKSON STREET, DENVER, CO 80206 FACILITY/ENTITY TYPE: PRIVATE, NOT-FOR-PROFIT ACADEMIC MEDICAL CENT…	Department of Health and Human Services Health Resources and Services Administration	93.965 COAL MINERS RESPIRATORY IMPAIRMENT TREATMENT CLINICS AND SERVICES	DENVER, CO-90	2024	$6,150,808
ASST_NON_CE152490_075 COMMUNITY PROJECT FUNDING/CONGRESSIONALLY DIRECTED SPENDING - CONSTRUCTION	Department of Health and Human Services Health Resources and Services Administration	93.493 CONGRESSIONAL DIRECTIVES	DENVER, CO-90	2024	$6,075,000
ASST_NON_R01AI018785_075 CHARACTERISTICS OF T CELL RECEPTORS - PROJECT SUMMARY IT IS WELL KNOWN THAT PARTICULAR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) ALLELES PROMOTE THE APPEARANCE OF MANY AUTOIMMUNE DIS…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$5,420,328
ASST_NON_R01HL130938_075 MECHANISMS OF LUNG MACROPHAGE PROGRAMMING BY MUC5B DURING HEALTH AND DISEASE - PROJECT SUMMARY MUCUS AND MACROPHAGES PROTECT THE LUNGS IN HEALTH, BUT THEY CAN ALSO CONTRIBUTE TO D…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	AURORA, CO-06	2024	$5,238,641
ASST_NON_R01HL122995_075 ASTHMA SUSCEPTIBILITY DUE TO ENVIRONMENTAL PROGRAMMING OF INNATE IMMUNITY IN UTERO - PROJECT SUMMARY/ABSTRACT A GROWING NUMBER OF EPIDEMIOLOGICAL STUDIES LINK CHILDHOOD ASTHMA WIT…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$5,201,027
ASST_NON_UH3TR002445_075 USE OF THE SRC FAMILY KINASE INHIBITOR SARACATINIB IN THE TREATMENT OF PULMONARY FIBROSIS - PROJECT SUMMARY IDIOPATHIC PULMONARY FIBROSIS (IPF) IS A CHRONIC, PROGRESSIVE, AND ULTI…	Department of Health and Human Services National Institutes of Health	93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES	CO-90	2024	$4,998,670
ASST_NON_R35HL161238_075 MESENCHYMAL VASCULAR PROGENITOR DEPLETION PROMOTES LUNG AGING AND SUSCEPTIBILITY TO EMPHYSEMA - THE OVERALL MISSION OF THIS RESEARCH PROGRAM IS TO DEFINE HOW PULMONARY MESENCHYMAL…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$4,910,279
ASST_NON_T32AI074491_075 MOLECULAR MECHANISMS OF IMMUNE TOLERANCE - PROJECT SUMMARY/ABSTRACT WE APPLY FOR RENEWAL OF A T32 POSTDOCTORAL TRAINING PROGRAM TO SUPPORT 5 POSTDOCTORAL TRAINEES STUDYING MOLECUL…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2025	$4,135,816
ASST_NON_R01HL135156_075 TRANSCRIPTOMIC AND PHARMACOGENETIC ASTHMA ENDOTYPES IN MINORITY CHILDREN - PROJECT SUMMARY ASTHMA AFFECTS 5% OF THE WORLD POPULATION. IN THE U.S., ASTHMA DEATH RATES ARE FOUR-FOLD…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2025	$4,056,698
ASST_NON_R01HL136681_075 A PROSPECTIVE STUDY OF T CELL IMMUNE-PHENOTYPE AND DISEASE OUTCOME IN PULMONARY SARCOIDOSIS - PROJECT SUMMARY/ABSTRACT: SARCOIDOSIS IS A GRANULOMATOUS DISEASE OF UNKNOWN ETIOLOGY…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$4,035,168
ASST_NON_R01HL144727_075 MECHANISMS OF RIGHT VENTRICLE ADAPTATION TO PULMONARY HYPERTENSION - THIS RENEWAL PROPOSAL BUILDS ON THE SCIENTIFIC PREMISE THAT EVEN THOUGH RIGHT VENTRICLE (RV) FUNCTION AND FEMA…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$3,993,211
ASST_NON_U01ES029430_075 OPTIMIZATION OF AEOL10150 TREATMENT OF SULFUR MUSTARD-INDUCED LUNG TOXIDROME IN A PIG MODEL - OUR LONG TERM GOAL IS TO DEVELOP THE CATALYTIC ANTIOXIDANT AEOL10150 AS MEDICAL COUNT…	Department of Health and Human Services National Institutes of Health	93.310 TRANS-NIH RESEARCH SUPPORT	CO-90	2024	$3,849,551
ASST_NON_R01AI152504_075 PARKIN IN MITOCHONDRIAL DYSFUNCTION AND AIRWAY INFLAMMATION OF OBESE ASTHMA - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS R01 APPLICATION IS TO DETERMINE THE MECHANISMS BY WHICH MIT…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$3,663,256
ASST_NON_R01HL137995_075 BIOMARKER OF LUNG DISEASE IN AFRICAN AMERICANS - PROJECT SUMMARY/ABSTRACT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS THE 3RD LEADING CAUSE OF DEATH IN THE US1,2. ALTHOUGH CO…	Department of Health and Human Services National Institutes of Health	93.310 TRANS-NIH RESEARCH SUPPORT	CO-90	2025	$3,357,184
ASST_NON_R01HL141264_075 ROLE OF FABP5 IN COPD EXACERBATIONS - PROJECT SUMMARY INFLAMMATION UNDERLIES THE PATHOGENESIS OF MANY CHRONIC LUNG DISEASES. THUS, DEFINING MECHANISMS BY WHICH PULMONARY INFLAMMAT…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$3,162,899
ASST_NON_R01ES033678_075 USING MULTI-OMICS TO DEFINE REGULATORS AND DRIVERS OF GRANULOMATOUS INFLAMMATION AND CHRONIC BERYLLIUM DISEASE - PROJECT SUMMARY/ABSTRACT: THE GOAL OF THIS STUDY IS TO DEFINE CELL…	Department of Health and Human Services National Institutes of Health	93.113 ENVIRONMENTAL HEALTH	DENVER, CO-01	2024	$3,147,568
ASST_NON_R01AI135194_075 REGULATION OF GENE EXPRESSION IN THE ANAPHYLACTIC PATHWAY - PROJECT SUMMARY THIS PROPOSAL INVESTIGATES THE REGULATION OF THREE SELECTED GENES THAT ENCODE PROTEINS THAT ARE CRITICA…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2025	$3,139,490
ASST_NON_R01AI141389_075 NEUTROPHIL NOX2 CONTROLS MONONUCLEAR CELL FUNCTIONS IN INFLAMMATION; ROLE IN CGD - PROJECT SUMMARY / ABSTRACT CHRONIC GRANULOMATOUS DISEASE (CGD) IS A RARE, BUT DEVASTATING, DISEA…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2025	$3,128,324
ASST_NON_U01AR077511_075 IDENTIFICATION OF PATHWAYS TO MITIGATE IMMUNE-RELATED ADVERSE EVENTS WITH CANCER IMMUNOTHERAPY - PROJECT SUMMARY / ABSTRACT: THE EMERGENCE OF IMMUNE CHECKPOINT INHIBITORS (CPIS)…	Department of Health and Human Services National Institutes of Health	93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT	CO-90	2024	$3,076,377
ASST_NON_R01AI157138_075 ILC2 MEMORY IN ASTHMA - ABSTRACT NON-ALLERGIC ASTHMA CONSTITUTES ABOUT 30% OF THE ADULT ASTHMA POPULATION AND IS FREQUENTLY ASSOCIATED WITH SEVERE ASTHMA. UNLIKE THAT OF ALLERGIC…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$3,059,940
ASST_NON_R01HL149741_075 ROLES FOR INTERSTITIAL AND AIRSPACE MACROPHAGES IN RESOLUTION OF PULMONARY INFLAMMATION - PROJECT SUMMARY/ABSTRACT INFLAMMATION IS IS A HIGHLY COMPLEX PROCESS THAT IS A COMPONENT…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2025	$3,031,587
ASST_NON_R01HL126125_075 THE BREATHEWELL PROGRAM TO IMPROVE ASTHMA OUTCOMES - DESCRIPTION (PROVIDED BY APPLICANT): DESPITE ESTABLISHED, EVIDENCE-BASED THERAPIES, MAJOR GAPS EXIST IN ASTHMA TREATMENT,…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$2,976,934
ASST_NON_R01AI150082_075 ROLE OF IMMUNOPROTEASOME IN AIRWAY VIRAL INFECTION - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS PROPOSAL IS TO DETERMINE THE REGULATION AND FUNCTIONS OF IMMUNOPROTEASOME (IP) DURIN…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	DENVER, CO-01	2024	$2,810,606
ASST_NON_U01AI173502_075 SUNBEAM BIRTH COHORT SUPPLEMENT - PROJECT SUMMARY/ABSTRACT NO CHANGE. NOT REQUIRED PER NOFO PA-20-272 PART 2 SECTION IV PARAGRAPH 2.	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	DENVER, CO-01	2024	$2,806,605
ASST_NON_R01HL140357_075 EPIGENETIC REGULATION OF IMMUNE PATHWAYS IN SARCOIDOSIS - PROJECT SUMMARY/ABSTRACT THE GOAL OF THIS STUDY IS TO DEFINE THE EPIGENETIC MARKS AND THEIR IMPACT ON GENE EXPRESSION THA…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$2,797,880
ASST_NON_R01HL157424_075 PROTEOLYSIS IN THE PATHOGENESIS OF ARDS - PROJECT SUMMARY/ABSTRACT THE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IS THE SEVEREST FORM OF ACUTE LUNG INJURY (ALI), AND IS CHARACTER…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$2,785,315
CONT_AWD_75N92023F00002_7529_75N92023D00011_7529 COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"	Department of Health and Human Services National Institutes of Health	—	DENVER, CO-01	2024	$2,769,465
ASST_NON_R01AI156901_075 THE ORIGIN AND ROLE OF PULMONARY ILC2 SUBSETS IN ANTI-HELMINTH IMMUNITY - PROJECT SUMMARY THE WORLD HEALTH ORGANIZATION ESTIMATES THAT SOIL TRANSMITTED HELMINTHS INFECT 1 IN 4 PEO…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$2,763,329
ASST_NON_R01AG073317_075 LOSS OF PROGENITOR FUNCTION ACCELERATES LUNG AGING - AGING IS ASSOCIATED WITH LOSS OF LUNG STRUCTURE AND DECLINING FUNCTION. EMPHYSEMATOUS LOSS OF TISSUE STRUCTURE IS EXACERBATED…	Department of Health and Human Services National Institutes of Health	93.866 AGING RESEARCH	DENVER, CO-01	2024	$2,747,723
ASST_NON_R01AI155749_075 MDS-ASSOCIATED SPLICEOSOME MUTATIONS REGULATE HOST DEFENSE - ABSTRACT MYELODYSPLASTIC SYNDROME (MDS) IS A HEMATOPOIETIC STEM CELL DISORDER CHARACTERIZED BY MYELOID CELL DIFFERENTI…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	DENVER, CO-01	2024	$2,696,549
ASST_NON_R01HL147860_075 REDUCING FIBROBLAST PERSISTENCE IN PULMONARY FIBROSIS AS A MECHANISM OF RESOLUTION - PROJECT SUMMARY INTERSTITIAL LUNG DISEASES (ILD) INCLUDE A DEVASTATING GROUP OF FIBROTIC PARE…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2026	$2,676,142
ASST_NON_HT94252410229_097 ROLE OF BURN PIT-RELATED PARTICULATE MATTER IN DRIVING DEPLOYMENT-RELATED LUNG DISEASE	Department of Defense Defense Health Agency	12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT	DENVER, CO-01	2024	$2,650,080
ASST_NON_R01AI143837_075 MATERNAL PROGRAMMING OF THE STEM CELL-BASOPHIL AXIS FOR ASTHMA - PROJECT SUMMARY/ABSTRACT A GROWING NUMBER OF EPIDEMIOLOGICAL STUDIES LINK CHILDHOOD ASTHMA WITH MATERNAL ENVIRONME…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	CO-90	2024	$2,553,445
ASST_NON_R01HL142049_075 NOVEL INTEGRATIVE APPROACHES FOR DISEASE PHENOTYPING, UTILIZING RADIOMICS IN SARCOIDOSIS - PROJECT SUMMARY/ABSTRACT THE GOALS OF THIS PROPOSAL ARE TO DEVELOP REPRODUCIBLE RADIOGRA…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$2,521,245
ASST_NON_R01HL148437_075 DEVELOPMENT AND VALIDATION OF A PROGNOSTIC TRANSCRIPTOMIC SIGNATURE FOR CHRONIC HYPERSENSITIVITY PNEUMONITIS - PROJECT SUMMARY/ABSTRACT: HYPERSENSITIVITY PNEUMONITIS (HP) IS AN IM…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	CO-90	2024	$2,512,296
ASST_NON_R01HL140595_075 FIBROBLAST RESISTANCE TO APOPTOSIS IN PULMONARY FIBROSIS - PROJECT SUMMARY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) AND IDIOPATHIC PULMONARY FIBROSIS (IPF) DEVELOP IN RESPONSE…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$2,458,836
ASST_NON_R01AI165922_075 DNA INDUCTION OF NEUTROPHILIC ASTHMA - PROJECT SUMMARY NEUTROPHILIC ASTHMA IS A SUBTYPE OF SEVERE ASTHMA, WHICH HAS NO SAFE AND EFFECTIVE THERAPY. THERE IS AN UNMET NEED TO DELINE…	Department of Health and Human Services National Institutes of Health	93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH	DENVER, CO-01	2024	$2,455,981
ASST_NON_R01HL162955_075 MOLECULAR CHARACTERIZATION OF PROGRESSIVE PULMONARY SARCOIDOSIS - PROJECT SUMMARY PULMONARY INVOLVEMENT OCCURS IN UP TO 90% OF SARCOIDOSIS CASES, THE DISEASE COURSE IS HETEROGENEO…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$2,384,181
ASST_NON_R01DA047341_075 USE OF BLINDED TAPERING FOR HYPNOTIC DISCONTINUATION - PROJECT SUMMARY/ABSTRACT TREATMENT-SEEKING INSOMNIA SUFFERERS MOST OFTEN PRESENT IN PRIMARY CARE VENUES WHERE THE FIRST AND…	Department of Health and Human Services National Institutes of Health	93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS	CO-90	2024	$2,355,506
ASST_NON_R01HL155325_075 CONTRIBUTION OF PULMONARY IONOCYTES AND NEUROENDOCRINE CELLS TO ION TRANSPORT-MEDIATED AIRWAY SURFACE LIQUID MAINTENANCE - PROJECT SUMMARY/ABSTRACT REGULATION OF ION TRANSPORT AC…	Department of Health and Human Services National Institutes of Health	93.837 CARDIOVASCULAR DISEASES RESEARCH	DENVER, CO-01	2024	$2,318,122

Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.